Giving in to patient demands for brand-name drugs could be adding unnecessary...
Physicians giving in to patient requests for brand-name medications even when suitable generics are available could be adding substantial unnecessary costs to the healthcare system, according to...
View ArticleClik here to view.
Glaucoma medical therapy sees new approvals
Take-Home New products and medications for surgery became available in 2013, while a heavy eye remained concentrated on the cost of generics. Dr. Fechtner By Cheryl Guttman Krader; Reviewed by Robert...
View ArticlePlans under pressure to balance formularies
Express Scripts and CVS Caremark are expected to expand their list of non-covered drugs for the 2015 plan year, leading to challenging pricing negotiations between branded pharmaceutical companies and...
View ArticleClik here to view.
Brand vs. generic: Which is best cataract surgery medicine?
Take home Substituting generic products for brand name innovators in cataract surgery medication regimens can bring trade-offs in efficacy, safety, and convenience, perhaps with just modest savings...
View ArticleFederal court finds two Latisse patents invalid
Washington, D.C.—The U.S. Court of Appeals for the Federal Circuit in Washington, D.C. recently found a pair of patents for Allergan’s Latisse (bimatoprost) invalid and threw out an order preventing...
View ArticleGenerics vs. brand-name drugs—different but still safe
Las Vegas—Despite some perceptions, generic pharmaceutical drugs are not necessarily less effective than their branded counterparts. But their true claim to fame is in cheaper pricing, undercutting the...
View ArticleFDA approves Copaxone for MS; problems persist
FDA approved the first generic version of Copaxone (glatiramer acetate injection) for treating patients with relapsing forms of multiple sclerosis (MS). Manufacturer Sandoz with Momenta has received...
View ArticleFDA approves first generic Abilify
FDA approved the first generic versions of Abilify (aripiprazole), an antipsychotic drug approved to treat schizophrenia and bipolar disorder, on April 28. Abilify is manufactured by Otsuka.Alembic...
View ArticleClik here to view.
FDA moves forward with approval of generic Abilify from 4 different...
FDA’s approval of generic versions of Abilify (aripiprazole), an antipsychotic drug approved to treat schizophrenia and bipolar disorder, from 4 different generic manufacturers, has industry insiders...
View ArticleClik here to view.
2015's glaucoma therapy advances
Reviewed by Neeru Gupta, MD, PhD, MBA, and Kuldev Singh, MD, MPH While no new drug shook up the world of glaucoma in 2015, a variety of promising agents made incremental advances toward the market...
View ArticleClik here to view.
High-cost generic programs decrease drug spend in 5 plans
While the high cost of specialty drugs is expected, generics have always been a saving grace for drug costs. That isn’t necessarily so. Prices rose more than 10% in 2015, according to Truveris, a...
View Article
